type-2 diabetes
Conditions
Interventions
An intervention group and control group will be set up, and the intervention group will participate in the "
Kusurism"
adherence support program for three months.
pretest/posttest
Sponsors
MSD K.K.
Nihon Chouzai Co., Ltd. Japan Medical Research Institute Co, Ltd. Teikyo University Centre for Evidence-Based Medicine School of Pharmacy, Nihon University Macromill, Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects who are 20 years or older Subjects who are taking at least one oral hypoglycemic agent. Subjects who are visiting a Nihon-Chouzai pharmacy in Tokyo. Subjects who have access to internet-based services. Subjects who give informed consent.
Exclusion criteria
Exclusion criteria: Subjects who have a planned hospitalization in the next 6 months or are in a nursing home Subjects who cannot or do not want to operate a computer or never use web-based services Subjects who are receiving or plan to start renal dialysis Subjects who have prescription histories for depression, dementia, Parkinson's disease, or schizophrenia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| medication adherence measured by MMAS-4 | — |
Secondary
| Measure | Time frame |
|---|---|
| Pharmacy visit rate Variable Medication Possession Ratio; VMPR or variable MPR Attitude toward taking medicines Understanding levels of illness and treatment | — |
Countries
Japan
Contacts
Public ContactHASHIMOTO Sora
United Health Communication Co., Ltd. None
Outcome results
None listed